Skip to main content

TNF inhibitor

      Virtual EULAR 2020 Round Up
      In this week's podcast, Drs. Artie Kavanaugh and Jack Cush present highlights from the virtual EULAR2020 meeting held June 3-6, 2020. Featured reports include: SELECT-CHOICE study. ABA vs. UPA in…
      These were my top abstracts from Thursday, 4th of June at EULAR 2020: Long Delays in Denosumab Increase Fracture Risk (SAT0453).  A UK population based study looked at risk of fracture in…
      These were my top abstracts from Thursday, 4th of June at EULAR 2020: Voclosporin Effective in Lupus Nephritis (OP0277). Voclosporin is a calcineurin inhibitor that has performed well in an…
      SELECT-Choice: UPA vs ABA in RA

      Dr. Jack Cush from EULAR2020 Virtual Conference

      OP0151

      Updated EULAR Recommendations for RA Management

      Dr. Kathryn Dao from EULAR2020 Virtual Conference

      Imaging and Remission Axial Spondyloarthritis

      Dr. Olga Petryna from EULAR2020 Virtual Conference

      OP0079 - what MRI findings are most predictive in AxSpa

      OP0314 - Drug free remission in AxSpA

      RT @uptoTate: Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before
      4 years 6 months ago
      Study in Norway reveals that the majority of the women w/ SpA were not treated with TNF inhibitors before or during pregnancy. Few on TNFi were continued on tx during pregnancy. #EULAR2020 @RheumNow https://t.co/t7B6pASeWQ https://t.co/BwU6RF5Qkn
      RT @uptoTate: Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 pat
      4 years 6 months ago
      Switching TNFi to VDZ in pts IBD-related SpA associated w/ articular exacerbation of SpA in 1 out of 4 patients within the first 5 months. New-onset MEM is also observed in up to 15% of patients with IBD treated with VDZ. #EULAR2020 @RheumNow https://t.co/ZVjZC7hvxs https://t.co/d1RT3GzB2b
      RT @KDAO2011: #EULAR2020 Recc for irAEs w/ICI:
      1. GC's ok, goal<10 mg/d, any csDMARD, bDMARD (TNFi/IL-6),🚫ABT xcep
      4 years 6 months ago
      #EULAR2020 Recc for irAEs w/ICI: 1. GC's ok, goal<10 mg/d, any csDMARD, bDMARD (TNFi/IL-6),🚫ABT xcept life-threatening myositis 2. Myositis beware bulbar signs: dysphagia, dysarthria, dysphonia: stop ICIs,⬆️GC, IVIG/PE 3. Don't test autoAbs b/f ICI Rx https://t.co/P5jDgnjK94
      ×